MEDPAL AI is trading at £5.07, up 7.89% in live trading on October 21, 2026; no clear company-specific catalyst has been identified.

  • The latest update, issued October 15, covered New Health’s Mounjaro ranking and customer growth; it does not establish a reason for the move.
  • Healthcare sector strength may be supporting the shares, with supplied sector context showing a 2.12% gain. This does not confirm the stock’s specific driver.